东宝生物：持股5%以上股东百纳盛远质押3.7398%公司股份

Core Viewpoint - Dongbao Bio announced that its major shareholder, Hainan Bainasengyuan Technology Co., Ltd., has pledged 33.3354 million shares, which accounts for 66.5958% of its holdings and 3.7398% of Dongbao Bio's total share capital. The pledge is for funding the construction of a project in Hainan, with Citic Securities as the pledgee [1]. Summary by Category - Shareholder Actions - Hainan Bainasengyuan Technology Co., Ltd. pledged 33.3354 million shares [1] - The pledged shares represent 66.5958% of the shareholder's total holdings [1] - The pledged shares account for 3.7398% of Dongbao Bio's total share capital [1] - Pledge Details - The pledge commenced on December 12, 2025 [1] - The purpose of the pledge is to meet funding needs for a project in Hainan [1] - Citic Securities is the designated pledgee [1]